idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instance:
Share on: 
02/18/2021 09:53

The "Crispr/Cas" for the chemical industry

Rainer Klose Kommunikation
Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

    After a successful career in research at Empa, Matthias Koebel has now ventured into the private sector and founded the start-up Siloxene. The young entrepreneur has a construction kit filled with a miracle material, a lot of know-how and – despite the general mood of crisis – a refreshing optimism.

    What Matthias Koebel is offering in his portfolio sounds almost like the Crispr/Cas genetic scissors, which were awarded the Nobel Prize for Medicine and can be used to specifically cure genetic diseases. Only for the chemical industry: a multifunctional material component that improves the properties of adhesives, coatings or fillers, depending on the product and customer requirements.

    Strictly speaking, this component is a silicon-based, molecular hybrid building material that is only about one nanometer in size. If used correctly, this "tentacle molecule" can specifically improve the properties of certain substances. For example, coatings can become more scratch-resistant, adhesives can have better adhesion or shorter curing times, or fillers can interact more specifically with a resin matrix. With this "multifunctional Lego building block" in his pocket, as Koebel calls it, the researcher recently founded the start-up Siloxene AG. Koebel discovered and investigated the component during his time as a scientist and head of Empa's "Building Energy Materials and Components" lab.


    Knowhow, technology and a lot of verve

    Besides the raw material, i.e. the macromolecule, he also received the second important component that forms the Siloxene portfolio from Empa: the know-how that is essential in the development of complex chemical products. Siloxene focuses on companies in the plastics processing, adhesives or sealants manufacturing, and building materials industries. "Here, the regulatory hurdles are not as high and we can work with companies to optimize their products and processes relatively easily," Koebel explains. Behind the formulation of an adhesive, for example, there are precisely coordinated mixtures of different chemical substances whose interaction must be understood in order to then make a targeted change.

    At the moment, he and his four-person team are already working with various companies on new developments. In such a process, the corporate customers primarily work on their own product formulation, while Siloxene provides technological advice, i.e. how the macromolecule can best be used in a specific case, and makes it available as a raw material. Depending on the need and application, this is also adapted. "For industrial companies, especially in the current crisis, there is an opportunity to invest in research and development, to develop and improve products. We are greatly benefiting from this," says Koebel.


    Own production in mind

    In general, there is little sense of crisis when you talk to Koebel. The financing for a good start has been secured, he says. Koebel can now concentrate on building up his own research and development department and acquiring more corporate customers. In addition, the energetic neo-entrepreneur already has a vision for the next five years: "At the beginning, we will probably have our macromolecule produced by a contract manufacturer. In the long term, however, I would like to set up our own production. I'm an optimist by nature and always look ahead and keep going, no matter what."


    Contact for scientific information:

    Dr. Matthias Koebel
    CEO, Siloxene AG
    Phone: +41 44 545 04 21
    m.koebel@siloxene.com


    More information:

    https://www.empa.ch/web/s604/siloxene
    https://siloxene.com/#top


    Images

    Matthias Koebel has been CEO of the newly founded Empa start-up Siloxene AG since the beginning of 2021.
    Matthias Koebel has been CEO of the newly founded Empa start-up Siloxene AG since the beginning of 2 ...

    Empa


    Criteria of this press release:
    Journalists
    Chemistry, Construction / architecture, Energy, Materials sciences
    transregional, national
    Personnel announcements, Transfer of Science or Research
    English


     

    Matthias Koebel has been CEO of the newly founded Empa start-up Siloxene AG since the beginning of 2021.


    For download

    x

    Help

    Search / advanced search of the idw archives
    Combination of search terms

    You can combine search terms with and, or and/or not, e.g. Philo not logy.

    Brackets

    You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).

    Phrases

    Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.

    Selection criteria

    You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).

    If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).